Clinical decision support to promote safe prescribing to women of reproductive age: A cluster-randomized trial

Eleanor Schwarz, Sara M. Parisi, Steven M. Handler, Gideon Koren, Elan D. Cohen, Grant J. Shevchik, Gary S. Fischer

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Potentially teratogenic medications are frequently prescribed without provision of contraceptive counseling. Objective: To evaluate whether computerized clinical decision support (CDS) can increase primary care providers' (PCPs') provision of family planning services when prescribing potentially teratogenic medications. Design: Cluster-randomized trial conducted in one academic and one community-based practice between October of 2008 and April of 2010. PARTICIPANTS/INTERVENTIONS: Forty-one PCPs were randomized to receive one of two types of CDS which alerted them to risks of medication-induced birth defects when ordering potentially teratogenic medications for women who may become pregnant. The 'simple' CDS provided a cautionary alert; the 'multifaceted' CDS provided tailored information and links to a structured order set Designed to facilitate safe prescribing. Both CDS systems alerted PCPs about medication risk only once per encounter. Main Measures: We assessed change in documented provision of family planning services using data from 35,110 encounters and mixed-effects models. PCPs completed surveys before and after the CDS systems were implemented, allowing assessment of change in PCP-reported counseling about the risks of medication-induced birth defects and contraception. Key Results: Both CDS systems were associated with slight increases in provision of family planning services when potential teratogens were prescribed, without a significant difference in improvement by CDS complexity (p∈=∈0.87). Because CDS was not repeated, 13% of the times that PCPs received CDS they substituted another potential teratogen. PCPs reported significant improvements in several counseling and prescribing practices. The multifaceted group reported a greater increase in the number of times per month they discussed the risks of medication use during pregnancy (multifaceted: +4.9∈±∈7.0 vs. simple: +0. 8∈±∈3.2, p∈=∈0.03). The simple CDS system was associated with greater clinician satisfaction. Conclusions: CDS systems hold promise for increasing provision of family planning services when fertile women are prescribed potentially teratogenic medications, but further refinement of these systems is needed.

Original languageEnglish (US)
Pages (from-to)831-838
Number of pages8
JournalJournal of General Internal Medicine
Volume27
Issue number7
DOIs
StatePublished - Jul 1 2012
Externally publishedYes

Fingerprint

Clinical Decision Support Systems
Family Planning Services
Teratogens
Counseling
Contraceptive Agents
Contraception

Keywords

  • birth defects
  • contraceptive counseling
  • decision support
  • health IT
  • preconception care

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Clinical decision support to promote safe prescribing to women of reproductive age : A cluster-randomized trial. / Schwarz, Eleanor; Parisi, Sara M.; Handler, Steven M.; Koren, Gideon; Cohen, Elan D.; Shevchik, Grant J.; Fischer, Gary S.

In: Journal of General Internal Medicine, Vol. 27, No. 7, 01.07.2012, p. 831-838.

Research output: Contribution to journalArticle

Schwarz, Eleanor ; Parisi, Sara M. ; Handler, Steven M. ; Koren, Gideon ; Cohen, Elan D. ; Shevchik, Grant J. ; Fischer, Gary S. / Clinical decision support to promote safe prescribing to women of reproductive age : A cluster-randomized trial. In: Journal of General Internal Medicine. 2012 ; Vol. 27, No. 7. pp. 831-838.
@article{eb57812314e2421fb5c1ffba3b3fd11e,
title = "Clinical decision support to promote safe prescribing to women of reproductive age: A cluster-randomized trial",
abstract = "Background: Potentially teratogenic medications are frequently prescribed without provision of contraceptive counseling. Objective: To evaluate whether computerized clinical decision support (CDS) can increase primary care providers' (PCPs') provision of family planning services when prescribing potentially teratogenic medications. Design: Cluster-randomized trial conducted in one academic and one community-based practice between October of 2008 and April of 2010. PARTICIPANTS/INTERVENTIONS: Forty-one PCPs were randomized to receive one of two types of CDS which alerted them to risks of medication-induced birth defects when ordering potentially teratogenic medications for women who may become pregnant. The 'simple' CDS provided a cautionary alert; the 'multifaceted' CDS provided tailored information and links to a structured order set Designed to facilitate safe prescribing. Both CDS systems alerted PCPs about medication risk only once per encounter. Main Measures: We assessed change in documented provision of family planning services using data from 35,110 encounters and mixed-effects models. PCPs completed surveys before and after the CDS systems were implemented, allowing assessment of change in PCP-reported counseling about the risks of medication-induced birth defects and contraception. Key Results: Both CDS systems were associated with slight increases in provision of family planning services when potential teratogens were prescribed, without a significant difference in improvement by CDS complexity (p∈=∈0.87). Because CDS was not repeated, 13{\%} of the times that PCPs received CDS they substituted another potential teratogen. PCPs reported significant improvements in several counseling and prescribing practices. The multifaceted group reported a greater increase in the number of times per month they discussed the risks of medication use during pregnancy (multifaceted: +4.9∈±∈7.0 vs. simple: +0. 8∈±∈3.2, p∈=∈0.03). The simple CDS system was associated with greater clinician satisfaction. Conclusions: CDS systems hold promise for increasing provision of family planning services when fertile women are prescribed potentially teratogenic medications, but further refinement of these systems is needed.",
keywords = "birth defects, contraceptive counseling, decision support, health IT, preconception care",
author = "Eleanor Schwarz and Parisi, {Sara M.} and Handler, {Steven M.} and Gideon Koren and Cohen, {Elan D.} and Shevchik, {Grant J.} and Fischer, {Gary S.}",
year = "2012",
month = "7",
day = "1",
doi = "10.1007/s11606-012-1991-y",
language = "English (US)",
volume = "27",
pages = "831--838",
journal = "Journal of General Internal Medicine",
issn = "0884-8734",
publisher = "Springer New York",
number = "7",

}

TY - JOUR

T1 - Clinical decision support to promote safe prescribing to women of reproductive age

T2 - A cluster-randomized trial

AU - Schwarz, Eleanor

AU - Parisi, Sara M.

AU - Handler, Steven M.

AU - Koren, Gideon

AU - Cohen, Elan D.

AU - Shevchik, Grant J.

AU - Fischer, Gary S.

PY - 2012/7/1

Y1 - 2012/7/1

N2 - Background: Potentially teratogenic medications are frequently prescribed without provision of contraceptive counseling. Objective: To evaluate whether computerized clinical decision support (CDS) can increase primary care providers' (PCPs') provision of family planning services when prescribing potentially teratogenic medications. Design: Cluster-randomized trial conducted in one academic and one community-based practice between October of 2008 and April of 2010. PARTICIPANTS/INTERVENTIONS: Forty-one PCPs were randomized to receive one of two types of CDS which alerted them to risks of medication-induced birth defects when ordering potentially teratogenic medications for women who may become pregnant. The 'simple' CDS provided a cautionary alert; the 'multifaceted' CDS provided tailored information and links to a structured order set Designed to facilitate safe prescribing. Both CDS systems alerted PCPs about medication risk only once per encounter. Main Measures: We assessed change in documented provision of family planning services using data from 35,110 encounters and mixed-effects models. PCPs completed surveys before and after the CDS systems were implemented, allowing assessment of change in PCP-reported counseling about the risks of medication-induced birth defects and contraception. Key Results: Both CDS systems were associated with slight increases in provision of family planning services when potential teratogens were prescribed, without a significant difference in improvement by CDS complexity (p∈=∈0.87). Because CDS was not repeated, 13% of the times that PCPs received CDS they substituted another potential teratogen. PCPs reported significant improvements in several counseling and prescribing practices. The multifaceted group reported a greater increase in the number of times per month they discussed the risks of medication use during pregnancy (multifaceted: +4.9∈±∈7.0 vs. simple: +0. 8∈±∈3.2, p∈=∈0.03). The simple CDS system was associated with greater clinician satisfaction. Conclusions: CDS systems hold promise for increasing provision of family planning services when fertile women are prescribed potentially teratogenic medications, but further refinement of these systems is needed.

AB - Background: Potentially teratogenic medications are frequently prescribed without provision of contraceptive counseling. Objective: To evaluate whether computerized clinical decision support (CDS) can increase primary care providers' (PCPs') provision of family planning services when prescribing potentially teratogenic medications. Design: Cluster-randomized trial conducted in one academic and one community-based practice between October of 2008 and April of 2010. PARTICIPANTS/INTERVENTIONS: Forty-one PCPs were randomized to receive one of two types of CDS which alerted them to risks of medication-induced birth defects when ordering potentially teratogenic medications for women who may become pregnant. The 'simple' CDS provided a cautionary alert; the 'multifaceted' CDS provided tailored information and links to a structured order set Designed to facilitate safe prescribing. Both CDS systems alerted PCPs about medication risk only once per encounter. Main Measures: We assessed change in documented provision of family planning services using data from 35,110 encounters and mixed-effects models. PCPs completed surveys before and after the CDS systems were implemented, allowing assessment of change in PCP-reported counseling about the risks of medication-induced birth defects and contraception. Key Results: Both CDS systems were associated with slight increases in provision of family planning services when potential teratogens were prescribed, without a significant difference in improvement by CDS complexity (p∈=∈0.87). Because CDS was not repeated, 13% of the times that PCPs received CDS they substituted another potential teratogen. PCPs reported significant improvements in several counseling and prescribing practices. The multifaceted group reported a greater increase in the number of times per month they discussed the risks of medication use during pregnancy (multifaceted: +4.9∈±∈7.0 vs. simple: +0. 8∈±∈3.2, p∈=∈0.03). The simple CDS system was associated with greater clinician satisfaction. Conclusions: CDS systems hold promise for increasing provision of family planning services when fertile women are prescribed potentially teratogenic medications, but further refinement of these systems is needed.

KW - birth defects

KW - contraceptive counseling

KW - decision support

KW - health IT

KW - preconception care

UR - http://www.scopus.com/inward/record.url?scp=84862649575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862649575&partnerID=8YFLogxK

U2 - 10.1007/s11606-012-1991-y

DO - 10.1007/s11606-012-1991-y

M3 - Article

C2 - 22297687

AN - SCOPUS:84862649575

VL - 27

SP - 831

EP - 838

JO - Journal of General Internal Medicine

JF - Journal of General Internal Medicine

SN - 0884-8734

IS - 7

ER -